Moonlake Immunotherapeutics Earnings logo

MLTX

Moonlake Immunotherapeutics Earnings

$48.27

Earnings Summary

Revenue
$0Mn
Net Profits
$-40.25Mn
Net Profit Margins
-Inf%
Highlights
Revenue:

Moonlake Immunotherapeutics’s revenue fell -100% since last year same period to $0Mn in the Q1 2025. On a quarterly growth basis, Moonlake Immunotherapeutics has generated -100% fall in its revenue since last 3-months.

Net Profits:

Moonlake Immunotherapeutics’s net profit fell -194.38% since last year same period to $-40.25Mn in the Q1 2025. On a quarterly growth basis, Moonlake Immunotherapeutics has generated 11.73% jump in its net profits since last 3-months.

Net Profit Margins:

Moonlake Immunotherapeutics’s net profit margin fell -Inf% since last year same period to -Inf% in the Q1 2025. On a quarterly growth basis, Moonlake Immunotherapeutics has generated -Inf% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Moonlake Immunotherapeutics post its latest quarter earnings
EPS Estimate Current Quarter
-0.72
EPS Estimate Current Year
-0.72
Highlights
EPS Estimate Current Quarter:

Moonlake Immunotherapeutics’s earning per share (EPS) estimates for the current quarter stand at -0.72 - a 1.85% jump from last quarter’s estimates.

EPS Estimate Current Year:

Moonlake Immunotherapeutics’s earning per share (EPS) estimates for the current year stand at -0.72.

Key Ratios

Key ratios of the Moonlake Immunotherapeutics post its Q2 2025 earnings
Earning Per Share (EPS)
0
Highlights
Earning Per Share (EPS):

Moonlake Immunotherapeutics’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Moonlake Immunotherapeutics has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2025-05-12
-0.74
-0.63
14.34%
2025-08-07
-0.72
0
100%